ENTRY       K04450                      KO
NAME        ATF2, CREBP1
DEFINITION  cyclic AMP-dependent transcription factor ATF-2
PATHWAY     ko04010  MAPK signaling pathway
            ko04022  cGMP-PKG signaling pathway
            ko04151  PI3K-Akt signaling pathway
            ko04261  Adrenergic signaling in cardiomyocytes
            ko04668  TNF signaling pathway
            ko04728  Dopaminergic synapse
            ko04911  Insulin secretion
            ko04915  Estrogen signaling pathway
            ko04918  Thyroid hormone synthesis
            ko05030  Cocaine addiction
            ko05031  Amphetamine addiction
            ko05034  Alcoholism
            ko05161  Hepatitis B
            ko05164  Influenza A
            ko05166  HTLV-I infection
            ko05169  Epstein-Barr virus infection
            ko05203  Viral carcinogenesis
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04010 MAPK signaling pathway
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               04668 TNF signaling pathway
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               04022 cGMP - PKG signaling pathway
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               04151 PI3K-Akt signaling pathway
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
             Organismal Systems
              Endocrine system
               04911 Insulin secretion
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               04915 Estrogen signaling pathway
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               04918 Thyroid hormone synthesis
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
              Circulatory system
               04261 Adrenergic signaling in cardiomyocytes
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
              Nervous system
               04728 Dopaminergic synapse
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
             Human Diseases
              Cancers
               05203 Viral carcinogenesis
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
              Substance dependence
               05030 Cocaine addiction
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               05031 Amphetamine addiction
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               05034 Alcoholism
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
              Infectious diseases
               05166 HTLV-I infection
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               05164 Influenza A
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               05161 Hepatitis B
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
               05169 Epstein-Barr virus infection
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
            Transcription factors [BR:ko03000]
             Eukaryotic Type
              Basic leucine zipper (bZIP)
               AP-1(-like) components, CRE-BP/ATF
                K04450  ATF2, CREBP1; cyclic AMP-dependent transcription factor ATF-2
DBLINKS     GO: 0035497
GENES       HSA: 1386(ATF2)
            PTR: 101059354(ATF2) 739083(ATF2)
            GGO: 101135003(ATF2)
            MCF: 101925838
            MMU: 11909(Atf2)
            RNO: 81647(Atf2)
            CGE: 100754663(Atf2)
            HGL: 101717365(Atf2)
            TUP: 102473406 102495293(ATF2)
            CFA: 478806(ATF2)
            AML: 100474135(ATF2)
            FCA: 101090884(ATF2)
            PTG: 102954603(ATF2)
            BTA: 509827(ATF2)
            BOM: 102283891(ATF2)
            PHD: 102335809(ATF2)
            CHX: 102180634(ATF2)
            SSC: 100513441(ATF2)
            CFR: 102512476(ATF2)
            BACU: 102999133(ATF2)
            LVE: 103089070(ATF2)
            ECB: 100053304(ATF2)
            MYB: 102241887(ATF2)
            MYD: 102761389(ATF2)
            PALE: 102889014(ATF2)
            MDO: 100025939(ATF2)
            SHR: 100914193(ATF2)
            OAA: 100077942(ATF2)
            GGA: 395727(ATF2)
            MGP: 100549420
            TGU: 100226584(ATF2)
            FAB: 101812575(ATF2)
            PHI: 102105113(ATF2)
            APLA: 101800932(ATF2)
            FPG: 101912040(ATF2)
            FCH: 102052727(ATF2)
            CLV: 102084432(ATF2)
            ASN: 102387336(ATF2)
            AMJ: 102572172(ATF2)
            PSS: 102460331(ATF2)
            CMY: 102939131(ATF2)
            PBI: 103053462(ATF2)
            XLA: 378533(atf2)
            XTR: 100485532(atf2)
            DRE: 100006516(atf2)
            TRU: 101063333
            MZE: 101463949
            OLA: 101161843
            XMA: 102220808 102234028
            LCM: 102360640 102366239(ATF2)
            CMK: 103176469(atf2)
            BFO: BRAFLDRAFT_123989
            SPU: 577426
            AGA: AgaP_AGAP008416
            AAG: AaeL_AAEL013261
            AME: 100576527
            NVI: 100119270
            TCA: 663103
            BMOR: 100862750
            PHU: Phum_PHUM600910
            ISC: IscW_ISCW020204
            NVE: NEMVE_v1g34679
            HMG: 100213904
            TAD: TRIADDRAFT_60644
            AQU: 100632529
REFERENCE   PMID:18677098
  AUTHORS   Bhoumik A, Ronai Z
  TITLE     ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities.
  JOURNAL   Cell Cycle 7:2341-5 (2008)
///
